Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-042881
Filing Date
2004-09-02
Accepted
2004-09-02 21:40:20
Documents
2
Period of Report
2004-07-28

Document Format Files

Seq Description Document Type Size
1 7/28/2004 OPTION GRANT rrd51758.html 4  
1 7/28/2004 OPTION GRANT rrd51758.xml 4 3928
2 SECTION 16 POWER OF ATTORNEY rrd42860_48758.htm EX-24. 3084
  Complete submission text file 0001181431-04-042881.txt   8801
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O OXIGENE INC ONE COPLEY PLACE, SUITE 602 BOSTON MA 02116
LAFFER ARTHUR B (Reporting) CIK: 0001090307 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 041015125